- 全部删除
- 您的购物车当前为空
EGFR-IN-133(Compound 24)作为一种有效的EGFR抑制剂,针对EGFR野生型及其L858R/T790M、d19/T790M、L858R/T790M/C797S和d19/T790M/C797S的突变体显示出低纳摩尔级的抑制活性,其IC50分别为0.1、0.044、0.036、0.04和0.054 nM。此外,EGFR-IN-133展现出优异的药代动力学属性,并具有高口服暴露度。
EGFR-IN-133(Compound 24)作为一种有效的EGFR抑制剂,针对EGFR野生型及其L858R/T790M、d19/T790M、L858R/T790M/C797S和d19/T790M/C797S的突变体显示出低纳摩尔级的抑制活性,其IC50分别为0.1、0.044、0.036、0.04和0.054 nM。此外,EGFR-IN-133展现出优异的药代动力学属性,并具有高口服暴露度。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
EGFR-IN-133 相关产品
产品描述 | EGFR-IN-133 (Compound 24) serves as an inhibitor targeting various mutations of the EGFR, including the wild type, L858R/T790M, d19/T790M, L858R/T790M/C797S, and d19/T790M/C797S with respective IC50 values of 0.1, 0.044, 0.036, 0.04, and 0.054 nM. The compound exhibits favorable pharmacokinetic properties and high oral bioavailability. |
靶点活性 | EGFR (WT):0.1nM(IC50) |
分子量 | 537.56 |
分子式 | C27H29F2N7O3 |
CAS No. | 2809982-26-9 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容